InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: None

Wednesday, 04/11/2018 10:07:56 AM

Wednesday, April 11, 2018 10:07:56 AM

Post# of 232963
Integrity is all we have at the end of the day. I owe it to the long term shareholders on this board to disclose information regardless of its content that can add clarity to the status of this investment.

Nader’s email contained information that came from his heart and confirmed his commitment and confidence to develop and monetize Pro-140.

It seems clear that they realized the risk of a R/S with the current SP and available near term PR’s the only prudent thing to do was to cancel the play. The only thing that pisses me off is announcing the R/S a month prior without thinking through the scenario that has come to fruition. Either very poor judgement or something came up that we don’t know about.

On the positive nothing has changed with the science and I do believe they are going to have strong Mono Interim to the level that the investigation trial will be converted to a Pivotal P3 by the FDA. That is the catalyst that has huge upside - my question is how far down the road are we with the Mono Investigational in terms of releasing Interim Data?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News